pubmed-article:10208660 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10208660 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
pubmed-article:10208660 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
pubmed-article:10208660 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:10208660 | lifeskim:mentions | umls-concept:C0017968 | lld:lifeskim |
pubmed-article:10208660 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:10208660 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:10208660 | pubmed:dateCreated | 1999-5-27 | lld:pubmed |
pubmed-article:10208660 | pubmed:abstractText | Alterations in serum levels of several glycoprotein constituents are reported to be useful for treatment monitoring of cancer patients. The purpose of this study was to determine efficacy of sialic acid and seromucoid fraction as treatment monitors for head and neck (H&N) cancer patients undergoing radiotherapy (RT). | lld:pubmed |
pubmed-article:10208660 | pubmed:language | eng | lld:pubmed |
pubmed-article:10208660 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10208660 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10208660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10208660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10208660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10208660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10208660 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10208660 | pubmed:month | May | lld:pubmed |
pubmed-article:10208660 | pubmed:issn | 1043-3074 | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:PatelM MMM | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:PatelB PBP | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:BhatavdekarJ... | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:PatelD DDD | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:PatelP SPS | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:RavalG NGN | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:RawalR MRM | lld:pubmed |
pubmed-article:10208660 | pubmed:author | pubmed-author:DixitS ASA | lld:pubmed |
pubmed-article:10208660 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10208660 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:10208660 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10208660 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10208660 | pubmed:pagination | 192-7 | lld:pubmed |
pubmed-article:10208660 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:meshHeading | pubmed-meshheading:10208660... | lld:pubmed |
pubmed-article:10208660 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10208660 | pubmed:articleTitle | Evaluation of glycoprotein constituents in head and neck cancer patients undergoing radiotherapy. | lld:pubmed |
pubmed-article:10208660 | pubmed:affiliation | Department of Cancer Biology, The Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India. | lld:pubmed |
pubmed-article:10208660 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10208660 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |